Comments
Loading...
Karyopharm Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:KPTI | Benzinga
Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS
$-2.770
Quarterly Revenue
$30.02M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$142.13M
Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics | -$3.00 | — | — | — | $42.79M | — | — | — | 08/05/2025 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$4.85 | -$3.09 | -$2.77 | 10.36% | $33.13M | $35.12M | $30.02M | -14.54% | 05/12/2025 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$5.40 | -$4.05 | -$3.60 | 11.11% | $33.75M | $35.67M | $30.54M | -14.38% | 02/19/2025 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$4.50 | -$3.90 | -$3.90 | 0.00% | $36.01M | $37.79M | $38.78M | 2.63% | 11/05/2024 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$4.35 | -$4.50 | -$3.00 | 33.33% | $37.58M | $36.18M | $42.79M | 18.26% | 08/06/2024 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$4.50 | -$4.95 | -$4.80 | 3.03% | $38.70M | $34.47M | $33.13M | -3.90% | 05/08/2024 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$6.45 | -$4.65 | -$5.40 | -16.13% | $33.58M | $35.40M | $33.75M | -4.67% | 02/29/2024 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$6.75 | -$4.20 | -$4.50 | -7.14% | $36.15M | $37.28M | $36.01M | -3.41% | 11/02/2023 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$9.30 | -$5.10 | -$4.35 | 14.71% | $39.68M | $36.23M | $37.58M | 3.72% | 08/02/2023 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$7.95 | -$5.55 | -$4.50 | 18.92% | $47.67M | $36.60M | $38.70M | 5.73% | 05/04/2023 | Get Alert |
| KPTI | Karyopharm Therapeutics | $6.90 | -$5.25 | -$6.45 | -22.86% | $126.27M | $35.12M | $33.58M | -4.38% | 02/15/2023 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$10.35 | -$8.55 | -$6.75 | 21.05% | $37.69M | $34.56M | $36.15M | 4.59% | 11/03/2022 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$10.65 | -$9.45 | -$9.30 | 1.59% | $22.60M | $35.59M | $39.68M | 11.49% | 08/04/2022 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$11.55 | -$9.45 | -$7.95 | 15.87% | $23.26M | $34.17M | $47.67M | 39.51% | 05/05/2022 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$8.85 | -$7.35 | $6.90 | 193.88% | $35.10M | $50.49M | $126.27M | 150.09% | 02/08/2022 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$10.95 | -$10.05 | -$10.35 | -2.99% | $21.33M | $25.80M | $37.69M | 46.08% | 11/03/2021 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$9.45 | -$11.10 | -$10.65 | 4.05% | $33.51M | $25.64M | $22.60M | -11.85% | 08/05/2021 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$11.70 | -$10.65 | -$11.55 | -8.45% | $18.14M | $25.17M | $23.26M | -7.59% | 05/03/2021 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$11.40 | -$0.59 | -$8.85 | -1400.00% | $18.10M | $29.37M | $35.10M | 19.51% | 02/11/2021 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$10.05 | -$10.80 | -$10.95 | -1.39% | $13.15M | $21.45M | $21.33M | -0.55% | 11/02/2020 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$10.65 | -$8.70 | -$9.45 | -8.62% | $9.49M | $27.42M | $33.51M | 22.22% | 08/04/2020 | Get Alert |
Karyopharm Therapeutics (KPTI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $-2.77 | $-3.09 | 10.4 % |
| Q4 | 2025-02-19 | $-3.60 | $-4.05 | 11.1 % |
| Q3 | 2024-11-05 | $-3.90 | $-3.90 | 0.00 % |
| Q2 | 2024-08-06 | $-3.00 | $-4.50 | 33.3 % |
Karyopharm Therapeutics (KPTI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $30.02M | $35.12M | -14.5 % |
| Q4 | 2025-02-19 | $30.54M | $35.67M | -14.4 % |
| Q3 | 2024-11-05 | $38.78M | $37.79M | 2.63 % |
| Q2 | 2024-08-06 | $42.79M | $36.18M | 18.3 % |
FAQ
When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?
Karyopharm Therapeutics (KPTI) is scheduled to report earnings on August 5, 2025. The last reported earnings were for reported on May 12, 2025 for Q1.
What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?
The Actual EPS was $-2.77, which beat the estimate of $-3.09.
What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?
The Actual Revenue was $30M, which missed the estimate of $35.1M.
Browse earnings estimates, EPS, and revenue on all stocks.
